Optimizing Psychiatry Prior Authorization Automation

Klivira delivers comprehensive psychiatry prior authorization automation, specifically designed to navigate the intricate requirements for behavioral health services and specialty medications.

The operational burden of prior authorization in psychiatry, encompassing everything from inpatient admissions to high-cost specialty drugs, presents unique challenges for revenue cycle directors and PA coordinators. Manual workflows lead to delays, denials, and administrative overhead, impacting patient access to critical mental health care. Klivira's platform provides an automated solution tailored to the specific demands of psychiatric and substance use disorder (SUD) treatment.

The Unique Landscape of Psychiatry Prior Authorization

Psychiatry prior authorization workflows are characterized by a diverse range of services requiring approval, from inpatient and residential care to specialty pharmaceuticals and advanced therapies. These often involve complex clinical criteria, such as ASAM Criteria for SUD or specific documentation for treatment-resistant depression, making efficient, accurate submission critical for patient access and revenue integrity.

Common Psychiatry Services Requiring Prior Authorization

Inpatient psychiatric admission and continued stay (including SUD admissions with ASAM criteria)
Partial Hospitalization (PHP) and Intensive Outpatient (IOP) programs
Residential treatment for SUD and eating disorders
Specialty psychiatric medications: atypical antipsychotics (e.g., paliperidone palmitate), stimulants (controlled), esketamine (Spravato), brexanolone (Zulresso), zuranolone (Zurzuvae)
Electroconvulsive Therapy (ECT) and Transcranial Magnetic Stimulation (TMS)
Ketamine and esketamine clinics
Specialty drugs for tardive dyskinesia (e.g., valbenazine, deutetrabenazine)

Automating Documentation and Submission for Behavioral Health

Klivira's platform automates the assembly of documentation required for psychiatric prior authorizations, integrating directly with your EMR to pull relevant FHIR resources. This includes DSM-5-TR diagnoses, severity scales (PHQ-9, GAD-7, Beck scales), safety risk assessments, and prior treatment trials. For SUD cases, the system supports ASAM dimension documentation, ensuring fidelity to placement criteria. We route requests through optimal channels, including Da Vinci PAS API, X12 278, or payer portals, with fax as a fallback.

Addressing Common Psychiatry PA Denial Reasons

ASAM level mismatch: denials for residential care when ASAM dimensions indicate a lower level of care
Step therapy: insufficient documentation of prior antidepressant trials for TMS or oral medication trials for specialty injectables
Concurrent review denials: continued inpatient stay when severity criteria are no longer met per InterQual or MCG behavioral criteria
Parity-act violations: payer criteria that appear more restrictive than comparable medical-surgical benefits
Out-of-network treatment: particularly for residential SUD where in-network options are limited

Klivira's EMR Integration for Psychiatric Workflows

Our platform integrates with leading EMRs (Epic, Cerner, athenahealth, etc.) via SMART on FHIR and CDS Hooks, enabling real-time PA requirement detection at the point of order entry. This ensures that PA-required orders for psychiatric medications or services are identified immediately. Klivira's system then automatically pulls clinical notes, lab results, and prior therapy history, streamlining documentation assembly and reducing callbacks to clinicians. Approved authorization numbers are written back to the EMR, ensuring accurate claim submission.

Expedited Review and Compliance Considerations

Psychiatric and SUD emergencies often necessitate expedited authorization decisions. Klivira's workflow prioritizes these time-sensitive requests, adhering to federal mandates like CMS-0057-F for 24-hour expedited PA decision timeframes where applicable. Our policy engine also flags potential parity issues, aligning with MHPAEA considerations, and supports continuous concurrent review workflows critical for inpatient and residential stays. We recommend discussing these considerations with your compliance team.

Frequently asked questions

How does Klivira handle prior authorizations for controlled substances like ADHD stimulants?

Klivira's platform integrates with payer-specific rules to identify PA requirements for controlled substances. It automates the collection of necessary clinical documentation, such as diagnosis, prior treatment history, and prescriber attestations, and routes the request through the appropriate electronic channels like NCPDP SCRIPT ePA where supported, or X12 278, to streamline approval for these medications.

Can Klivira manage concurrent reviews for extended psychiatric inpatient or residential stays?

Yes, Klivira is designed to manage continuous concurrent review workflows. For psychiatric inpatient and residential stays, our system tracks authorization periods, automatically initiates requests for continued stay reviews based on payer requirements (e.g., InterQual or MCG behavioral criteria), and facilitates the submission of updated clinical documentation to support ongoing medical necessity.

How does Klivira address the specific documentation for TMS prior authorizations?

For TMS, Klivira automates the collection of documentation proving failed antidepressant trials, which is a common payer requirement. Our system can pull medication history, dosages, and durations directly from the EMR, assembling a comprehensive packet to meet step-therapy guidelines and support the medical necessity for transcranial magnetic stimulation.

What role does EMR integration play in automating psychiatry PA workflows?

EMR integration is foundational. Klivira leverages SMART on FHIR and CDS Hooks to detect PA requirements at the point of order entry within your EMR. This allows for automated documentation discovery (e.g., pulling DSM-5-TR diagnoses, PHQ-9 scores, ASAM dimensions) and direct write-back of authorization numbers, eliminating manual data entry and ensuring the auth number is available for downstream billing.

How does Klivira help with denials related to ASAM level-of-care criteria for SUD treatment?

Klivira's platform incorporates ASAM-criteria-aware logic into its policy engine. When a denial occurs due to an ASAM level mismatch, the system helps identify the specific dimensions where documentation may be lacking or misaligned. It can then assist in assembling additional supporting documentation for appeal, or flag cases for human clinical review when complex judgment is required.